ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Medical Grade Chitosan Market Research Report 2026
Published Date: 2026-02-26
|
Report Code: QYRE-Auto-13T5575
Home | Market Reports
Global Medical Grade Chitosan Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027
BUY CHAPTERS

Global Medical Grade Chitosan Market Research Report 2026

Code: QYRE-Auto-13T5575
Report
2026-02-26
Pages:127
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Primex
Kitozyme
BIO21
YSK
Vietnam Food
Novamatrix
KIMICA
Golden-Shell Pharmaceutical
Zhejiang Fengrun Biotech
Jiangsu Shuanglin
Jiangsu Aoxin Biotechnology
Qingdao Yunzhou Biochemistry
Heppe Medical Chitosan GmbH
ChitoLytic

Medical Grade Chitosan Market Size

The global Medical Grade Chitosan market was valued at US$ 67.48 million in 2025 and is anticipated to reach US$ 106 million by 2032, at a CAGR of 6.8% from 2026 to 2032.

Medical Grade Chitosan Market

Medical Grade Chitosan Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Medical Grade Chitosan competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
In the current market, medical-grade chitosan refers to highly purified, specification-controlled chitosan that meets pharmaceutical or medical device expectations on bioburden, residuals, and defined structural parameters such as degree of deacetylation and molecular-weight distribution. As a cationic polysaccharide obtained by partial deacetylation of chitin, it offers hemostatic action, film-forming, and bioadhesion that make it valuable for wound care, emergency hemostats, drug delivery matrices, and tissue scaffolds. Suppliers differentiate by source—marine crustacean versus non-animal fungal origin—by form (powder, solutions, or salts/derivatives), and by quality systems (e.g., ISO 13485 and EU-GMP) that enable use in regulated settings. USP/NF defines chitosan and accepts DDA in a 70–95% window, anchoring analytical consistency for buyers and regulators.
Upstream, the key inputs are chitin from shrimp and crab shells or fungal biomass, caustic/alcohols for deacetylation, and purified water and cleanroom capacity for high-grade finishing. The midstream consists of specialized producers such as Heppe Medical Chitosan (ISO 13485; EU-GMP-aligned cleanroom production), Primex (ChitoCare Medical materials for wound and skin indications), and KitoZyme (fungal, non-animal origin), as well as Asian producers with medical-grade product lines. Downstream users include wound-care and emergency hemostat manufacturers with cleared devices, pharmaceutical companies using chitosan as an excipient or delivery aid, and research/clinical groups in tissue engineering and oral care. Procurement commonly blends long-term framework supply with quality-system audits and lot-release documentation; device OEMs often reference cleared indications via 510(k). Industry gross margins in this niche typically land around the mid-20s due to quality-system overhead, batch yields, documentation, and the premium for non-animal or ultrapure grades. Representative clearances and manufacturer quality statements illustrate these patterns.
In the current market, global production is around 650 t with an average selling price of about USD 64.27 per kg(EXW basis). Top suppliers together control roughly half to two-thirds of value, driven by qualification hurdles and brand trust in regulated applications; the supply landscape features marine-sourced leaders in Europe and Asia and a growing non-animal fungal segment in Europe. Demand is most visible in North America and Europe where cleared hemostats and wound products are widely used, with China and the broader Indo-Pacific ramping on both the supply and demand sides. Toward 2025–2031, the direction is steady expansion into drug-delivery adjuncts and tissue engineering, gradual mix-shift toward non-animal sources where regulatory or customer preferences require it, and continuing cost/quality optimization. Potential bottlenecks include variability in upstream chitin supply, the capital and documentation burden of ISO 13485/EU-GMP production, and device-side regulatory timelines that pace downstream offtake. Illustrative evidence includes USP/NF definitions, 510(k) device clearances, and supplier quality disclosures.
This report delivers a comprehensive overview of the global Medical Grade Chitosan market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Medical Grade Chitosan. The Medical Grade Chitosan market size, estimates, and forecasts are provided in terms of sales volume (Ton) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Medical Grade Chitosan market comprehensively. Regional market sizes by Source, by Application, by Form, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Medical Grade Chitosan manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Source, by Application, and by region.
Market Segmentation

Scope of Medical Grade Chitosan Market Report

Report Metric Details
Report Name Medical Grade Chitosan Market
Accounted market size in 2025 US$ 67.48 in million
Forecasted market size in 2032 US$ 106 million
CAGR 6.8%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Source
  • Marine (Crustacean-derived)
  • Fungal (Non-animal)
Segment by Form
  • Powder/Flake
  • Salts & Derivatives
Segment by Channel
  • Direct Sale
  • Indirect Sale
by Application
  • Wound Care & Exudate Management
  • Hemostats & Emergency Care
  • Pharma Excipients & Drug Delivery
  • Tissue Engineering & Regenerative Medicine
  • Medical Cosmetology
  • Other Medical Uses
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Primex, KitoZyme, BIO21, YSK, Vietnam Food, NovaMatrix, KIMICA, Heppe Medical Chitosan GmbH, ChitoLytic, Golden-Shell Pharmaceutical, Zhejiang Fengrun Biotech, Jiangsu Shuanglin, Jiangsu Aoxin Biotechnology, Qingdao Yunzhou Biochemistry
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Source, by Application, by Form, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Medical Grade Chitosan manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Medical Grade Chitosan sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Source, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Medical Grade Chitosan Market growing?

Ans: The Medical Grade Chitosan Market witnessing a CAGR of 6.8% during the forecast period 2026-2032.

What is the Medical Grade Chitosan Market size in 2032?

Ans: The Medical Grade Chitosan Market size in 2032 will be US$ 106 million.

Who are the main players in the Medical Grade Chitosan Market report?

Ans: The main players in the Medical Grade Chitosan Market are Primex, KitoZyme, BIO21, YSK, Vietnam Food, NovaMatrix, KIMICA, Heppe Medical Chitosan GmbH, ChitoLytic, Golden-Shell Pharmaceutical, Zhejiang Fengrun Biotech, Jiangsu Shuanglin, Jiangsu Aoxin Biotechnology, Qingdao Yunzhou Biochemistry

What are the Application segmentation covered in the Medical Grade Chitosan Market report?

Ans: The Applications covered in the Medical Grade Chitosan Market report are Wound Care & Exudate Management, Hemostats & Emergency Care, Pharma Excipients & Drug Delivery, Tissue Engineering & Regenerative Medicine, Medical Cosmetology, Other Medical Uses

1 Medical Grade Chitosan Market Overview
1.1 Product Definition
1.2 Medical Grade Chitosan by Source
1.2.1 Global Medical Grade Chitosan Market Value by Source: 2025 vs 2032
1.2.2 Marine (Crustacean-derived)
1.2.3 Fungal (Non-animal)
1.3 Medical Grade Chitosan by Form
1.3.1 Global Medical Grade Chitosan Market Value by Form: 2025 vs 2032
1.3.2 Powder/Flake
1.3.3 Salts & Derivatives
1.4 Medical Grade Chitosan by Channel
1.4.1 Global Medical Grade Chitosan Market Value by Channel: 2025 vs 2032
1.4.2 Direct Sale
1.4.3 Indirect Sale
1.5 Medical Grade Chitosan by Application
1.5.1 Global Medical Grade Chitosan Market Value by Application: 2025 vs 2032
1.5.2 Wound Care & Exudate Management
1.5.3 Hemostats & Emergency Care
1.5.4 Pharma Excipients & Drug Delivery
1.5.5 Tissue Engineering & Regenerative Medicine
1.5.6 Medical Cosmetology
1.5.7 Other Medical Uses
1.6 Global Medical Grade Chitosan Market Size Estimates and Forecasts
1.6.1 Global Medical Grade Chitosan Revenue 2021–2032
1.6.2 Global Medical Grade Chitosan Sales 2021–2032
1.6.3 Global Medical Grade Chitosan Market Average Price (2021–2032)
1.7 Assumptions and Limitations
2 Medical Grade Chitosan Market Competition by Manufacturers
2.1 Global Medical Grade Chitosan Sales Market Share by Manufacturers (2021–2026)
2.2 Global Medical Grade Chitosan Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Medical Grade Chitosan Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Medical Grade Chitosan, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Medical Grade Chitosan, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Medical Grade Chitosan, Product Types and Applications
2.7 Global Key Manufacturers of Medical Grade Chitosan, Date of Entry into the Industry
2.8 Global Medical Grade Chitosan Market Competitive Situation and Trends
2.8.1 Global Medical Grade Chitosan Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Medical Grade Chitosan Players Market Share by Revenue
2.8.3 Global Medical Grade Chitosan Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Medical Grade Chitosan Market Scenario by Region
3.1 Global Medical Grade Chitosan Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Medical Grade Chitosan Sales by Region: 2021–2032
3.2.1 Global Medical Grade Chitosan Sales by Region: 2021–2026
3.2.2 Global Medical Grade Chitosan Sales by Region: 2027–2032
3.3 Global Medical Grade Chitosan Revenue by Region: 2021–2032
3.3.1 Global Medical Grade Chitosan Revenue by Region: 2021–2026
3.3.2 Global Medical Grade Chitosan Revenue by Region: 2027–2032
3.4 North America Medical Grade Chitosan Market Facts & Figures by Country
3.4.1 North America Medical Grade Chitosan Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Medical Grade Chitosan Sales by Country (2021–2032)
3.4.3 North America Medical Grade Chitosan Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Medical Grade Chitosan Market Facts & Figures by Country
3.5.1 Europe Medical Grade Chitosan Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Medical Grade Chitosan Sales by Country (2021–2032)
3.5.3 Europe Medical Grade Chitosan Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Medical Grade Chitosan Market Facts & Figures by Region
3.6.1 Asia Pacific Medical Grade Chitosan Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Medical Grade Chitosan Sales by Region (2021–2032)
3.6.3 Asia Pacific Medical Grade Chitosan Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Medical Grade Chitosan Market Facts & Figures by Country
3.7.1 Latin America Medical Grade Chitosan Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Medical Grade Chitosan Sales by Country (2021–2032)
3.7.3 Latin America Medical Grade Chitosan Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Medical Grade Chitosan Market Facts & Figures by Country
3.8.1 Middle East and Africa Medical Grade Chitosan Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Medical Grade Chitosan Sales by Country (2021–2032)
3.8.3 Middle East and Africa Medical Grade Chitosan Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Source
4.1 Global Medical Grade Chitosan Sales by Source (2021–2032)
4.1.1 Global Medical Grade Chitosan Sales by Source (2021–2026)
4.1.2 Global Medical Grade Chitosan Sales by Source (2027–2032)
4.1.3 Global Medical Grade Chitosan Sales Market Share by Source (2021–2032)
4.2 Global Medical Grade Chitosan Revenue by Source (2021–2032)
4.2.1 Global Medical Grade Chitosan Revenue by Source (2021–2026)
4.2.2 Global Medical Grade Chitosan Revenue by Source (2027–2032)
4.2.3 Global Medical Grade Chitosan Revenue Market Share by Source (2021–2032)
4.3 Global Medical Grade Chitosan Price by Source (2021–2032)
5 Segment by Application
5.1 Global Medical Grade Chitosan Sales by Application (2021–2032)
5.1.1 Global Medical Grade Chitosan Sales by Application (2021–2026)
5.1.2 Global Medical Grade Chitosan Sales by Application (2027–2032)
5.1.3 Global Medical Grade Chitosan Sales Market Share by Application (2021–2032)
5.2 Global Medical Grade Chitosan Revenue by Application (2021–2032)
5.2.1 Global Medical Grade Chitosan Revenue by Application (2021–2026)
5.2.2 Global Medical Grade Chitosan Revenue by Application (2027–2032)
5.2.3 Global Medical Grade Chitosan Revenue Market Share by Application (2021–2032)
5.3 Global Medical Grade Chitosan Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Primex
6.1.1 Primex Company Information
6.1.2 Primex Description and Business Overview
6.1.3 Primex Medical Grade Chitosan Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Primex Medical Grade Chitosan Product Portfolio
6.1.5 Primex Recent Developments/Updates
6.2 KitoZyme
6.2.1 KitoZyme Company Information
6.2.2 KitoZyme Description and Business Overview
6.2.3 KitoZyme Medical Grade Chitosan Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 KitoZyme Medical Grade Chitosan Product Portfolio
6.2.5 KitoZyme Recent Developments/Updates
6.3 BIO21
6.3.1 BIO21 Company Information
6.3.2 BIO21 Description and Business Overview
6.3.3 BIO21 Medical Grade Chitosan Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 BIO21 Medical Grade Chitosan Product Portfolio
6.3.5 BIO21 Recent Developments/Updates
6.4 YSK
6.4.1 YSK Company Information
6.4.2 YSK Description and Business Overview
6.4.3 YSK Medical Grade Chitosan Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 YSK Medical Grade Chitosan Product Portfolio
6.4.5 YSK Recent Developments/Updates
6.5 Vietnam Food
6.5.1 Vietnam Food Company Information
6.5.2 Vietnam Food Description and Business Overview
6.5.3 Vietnam Food Medical Grade Chitosan Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Vietnam Food Medical Grade Chitosan Product Portfolio
6.5.5 Vietnam Food Recent Developments/Updates
6.6 NovaMatrix
6.6.1 NovaMatrix Company Information
6.6.2 NovaMatrix Description and Business Overview
6.6.3 NovaMatrix Medical Grade Chitosan Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 NovaMatrix Medical Grade Chitosan Product Portfolio
6.6.5 NovaMatrix Recent Developments/Updates
6.7 KIMICA
6.7.1 KIMICA Company Information
6.7.2 KIMICA Description and Business Overview
6.7.3 KIMICA Medical Grade Chitosan Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 KIMICA Medical Grade Chitosan Product Portfolio
6.7.5 KIMICA Recent Developments/Updates
6.8 Heppe Medical Chitosan GmbH
6.8.1 Heppe Medical Chitosan GmbH Company Information
6.8.2 Heppe Medical Chitosan GmbH Description and Business Overview
6.8.3 Heppe Medical Chitosan GmbH Medical Grade Chitosan Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Heppe Medical Chitosan GmbH Medical Grade Chitosan Product Portfolio
6.8.5 Heppe Medical Chitosan GmbH Recent Developments/Updates
6.9 ChitoLytic
6.9.1 ChitoLytic Company Information
6.9.2 ChitoLytic Description and Business Overview
6.9.3 ChitoLytic Medical Grade Chitosan Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 ChitoLytic Medical Grade Chitosan Product Portfolio
6.9.5 ChitoLytic Recent Developments/Updates
6.10 Golden-Shell Pharmaceutical
6.10.1 Golden-Shell Pharmaceutical Company Information
6.10.2 Golden-Shell Pharmaceutical Description and Business Overview
6.10.3 Golden-Shell Pharmaceutical Medical Grade Chitosan Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Golden-Shell Pharmaceutical Medical Grade Chitosan Product Portfolio
6.10.5 Golden-Shell Pharmaceutical Recent Developments/Updates
6.11 Zhejiang Fengrun Biotech
6.11.1 Zhejiang Fengrun Biotech Company Information
6.11.2 Zhejiang Fengrun Biotech Description and Business Overview
6.11.3 Zhejiang Fengrun Biotech Medical Grade Chitosan Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Zhejiang Fengrun Biotech Medical Grade Chitosan Product Portfolio
6.11.5 Zhejiang Fengrun Biotech Recent Developments/Updates
6.12 Jiangsu Shuanglin
6.12.1 Jiangsu Shuanglin Company Information
6.12.2 Jiangsu Shuanglin Description and Business Overview
6.12.3 Jiangsu Shuanglin Medical Grade Chitosan Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Jiangsu Shuanglin Medical Grade Chitosan Product Portfolio
6.12.5 Jiangsu Shuanglin Recent Developments/Updates
6.13 Jiangsu Aoxin Biotechnology
6.13.1 Jiangsu Aoxin Biotechnology Company Information
6.13.2 Jiangsu Aoxin Biotechnology Description and Business Overview
6.13.3 Jiangsu Aoxin Biotechnology Medical Grade Chitosan Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Jiangsu Aoxin Biotechnology Medical Grade Chitosan Product Portfolio
6.13.5 Jiangsu Aoxin Biotechnology Recent Developments/Updates
6.14 Qingdao Yunzhou Biochemistry
6.14.1 Qingdao Yunzhou Biochemistry Company Information
6.14.2 Qingdao Yunzhou Biochemistry Description and Business Overview
6.14.3 Qingdao Yunzhou Biochemistry Medical Grade Chitosan Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Qingdao Yunzhou Biochemistry Medical Grade Chitosan Product Portfolio
6.14.5 Qingdao Yunzhou Biochemistry Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Medical Grade Chitosan Industry Chain Analysis
7.2 Medical Grade Chitosan Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Medical Grade Chitosan Production Mode & Process Analysis
7.4 Medical Grade Chitosan Sales and Marketing
7.4.1 Medical Grade Chitosan Sales Channels
7.4.2 Medical Grade Chitosan Distributors
7.5 Medical Grade Chitosan Customer Analysis
8 Medical Grade Chitosan Market Dynamics
8.1 Medical Grade Chitosan Industry Trends
8.2 Medical Grade Chitosan Market Drivers
8.3 Medical Grade Chitosan Market Challenges
8.4 Medical Grade Chitosan Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Primex
Kitozyme
BIO21
YSK
Vietnam Food
Novamatrix
KIMICA
Golden-Shell Pharmaceutical
Zhejiang Fengrun Biotech
Jiangsu Shuanglin
Jiangsu Aoxin Biotechnology
Qingdao Yunzhou Biochemistry
Heppe Medical Chitosan GmbH
ChitoLytic
List of Tables
 Table 1. Global Medical Grade Chitosan Market Value by Source (US$ Million), 2025 vs 2032
 Table 2. Global Medical Grade Chitosan Market Value by Form (US$ Million), 2025 vs 2032
 Table 3. Global Medical Grade Chitosan Market Value by Channel (US$ Million), 2025 vs 2032
 Table 4. Global Medical Grade Chitosan Market Value by Application (US$ Million), 2025 vs 2032
 Table 5. Global Medical Grade Chitosan Market Competitive Situation by Manufacturers in 2025
 Table 6. Global Medical Grade Chitosan Sales (Ton) of Key Manufacturers (2021–2026)
 Table 7. Global Medical Grade Chitosan Sales Market Share by Manufacturers (2021–2026)
 Table 8. Global Medical Grade Chitosan Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 9. Global Medical Grade Chitosan Revenue Share by Manufacturers (2021–2026)
 Table 10. Global Market Medical Grade Chitosan Average Price (US$/Kg) of Key Manufacturers (2021–2026)
 Table 11. Global Key Players of Medical Grade Chitosan, Industry Ranking, 2023 vs 2024 vs 2025
 Table 12. Global Key Manufacturers of Medical Grade Chitosan, Manufacturing Sites and Headquarters
 Table 13. Global Key Manufacturers of Medical Grade Chitosan, Product Types and Applications
 Table 14. Global Key Manufacturers of Medical Grade Chitosan, Date of Entry into the Industry
 Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 16. Global Medical Grade Chitosan Companies by Tier (Tier 1, Tier 2, Tier 3), based on Medical Grade Chitosan Revenue, 2025
 Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 18. Global Medical Grade Chitosan Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 19. Global Medical Grade Chitosan Sales by Region (Ton), 2021–2026
 Table 20. Global Medical Grade Chitosan Sales Market Share by Region (2021–2026)
 Table 21. Global Medical Grade Chitosan Sales by Region (Ton), 2027–2032
 Table 22. Global Medical Grade Chitosan Sales Market Share by Region (2027–2032)
 Table 23. Global Medical Grade Chitosan Revenue by Region (US$ Million), 2021–2026
 Table 24. Global Medical Grade Chitosan Revenue Market Share by Region (2021–2026)
 Table 25. Global Medical Grade Chitosan Revenue by Region (US$ Million), 2027–2032
 Table 26. Global Medical Grade Chitosan Revenue Market Share by Region (2027–2032)
 Table 27. North America Medical Grade Chitosan Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 28. North America Medical Grade Chitosan Sales by Country (Ton), 2021–2026
 Table 29. North America Medical Grade Chitosan Sales by Country (Ton), 2027–2032
 Table 30. North America Medical Grade Chitosan Revenue by Country (US$ Million), 2021–2026
 Table 31. North America Medical Grade Chitosan Revenue by Country (US$ Million), 2027–2032
 Table 32. Europe Medical Grade Chitosan Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 33. Europe Medical Grade Chitosan Sales by Country (Ton), 2021–2026
 Table 34. Europe Medical Grade Chitosan Sales by Country (Ton), 2027–2032
 Table 35. Europe Medical Grade Chitosan Revenue by Country (US$ Million), 2021–2026
 Table 36. Europe Medical Grade Chitosan Revenue by Country (US$ Million), 2027–2032
 Table 37. Asia Pacific Medical Grade Chitosan Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 38. Asia Pacific Medical Grade Chitosan Sales by Region (Ton), 2021–2026
 Table 39. Asia Pacific Medical Grade Chitosan Sales by Region (Ton), 2027–2032
 Table 40. Asia Pacific Medical Grade Chitosan Revenue by Region (US$ Million), 2021–2026
 Table 41. Asia Pacific Medical Grade Chitosan Revenue by Region (US$ Million), 2027–2032
 Table 42. Latin America Medical Grade Chitosan Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 43. Latin America Medical Grade Chitosan Sales by Country (Ton), 2021–2026
 Table 44. Latin America Medical Grade Chitosan Sales by Country (Ton), 2027–2032
 Table 45. Latin America Medical Grade Chitosan Revenue by Country (US$ Million), 2021–2026
 Table 46. Latin America Medical Grade Chitosan Revenue by Country (US$ Million), 2027–2032
 Table 47. Middle East and Africa Medical Grade Chitosan Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 48. Middle East and Africa Medical Grade Chitosan Sales by Country (Ton), 2021–2026
 Table 49. Middle East and Africa Medical Grade Chitosan Sales by Country (Ton), 2027–2032
 Table 50. Middle East and Africa Medical Grade Chitosan Revenue by Country (US$ Million), 2021–2026
 Table 51. Middle East and Africa Medical Grade Chitosan Revenue by Country (US$ Million), 2027–2032
 Table 52. Global Medical Grade Chitosan Sales (Ton) by Source (2021–2026)
 Table 53. Global Medical Grade Chitosan Sales (Ton) by Source (2027–2032)
 Table 54. Global Medical Grade Chitosan Sales Market Share by Source (2021–2026)
 Table 55. Global Medical Grade Chitosan Sales Market Share by Source (2027–2032)
 Table 56. Global Medical Grade Chitosan Revenue (US$ Million) by Source (2021–2026)
 Table 57. Global Medical Grade Chitosan Revenue (US$ Million) by Source (2027–2032)
 Table 58. Global Medical Grade Chitosan Revenue Market Share by Source (2021–2026)
 Table 59. Global Medical Grade Chitosan Revenue Market Share by Source (2027–2032)
 Table 60. Global Medical Grade Chitosan Price (US$/Kg) by Source (2021–2026)
 Table 61. Global Medical Grade Chitosan Price (US$/Kg) by Source (2027–2032)
 Table 62. Global Medical Grade Chitosan Sales (Ton) by Application (2021–2026)
 Table 63. Global Medical Grade Chitosan Sales (Ton) by Application (2027–2032)
 Table 64. Global Medical Grade Chitosan Sales Market Share by Application (2021–2026)
 Table 65. Global Medical Grade Chitosan Sales Market Share by Application (2027–2032)
 Table 66. Global Medical Grade Chitosan Revenue (US$ Million) by Application (2021–2026)
 Table 67. Global Medical Grade Chitosan Revenue (US$ Million) by Application (2027–2032)
 Table 68. Global Medical Grade Chitosan Revenue Market Share by Application (2021–2026)
 Table 69. Global Medical Grade Chitosan Revenue Market Share by Application (2027–2032)
 Table 70. Global Medical Grade Chitosan Price (US$/Kg) by Application (2021–2026)
 Table 71. Global Medical Grade Chitosan Price (US$/Kg) by Application (2027–2032)
 Table 72. Primex Company Information
 Table 73. Primex Description and Business Overview
 Table 74. Primex Medical Grade Chitosan Sales (Ton), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
 Table 75. Primex Medical Grade Chitosan Product
 Table 76. Primex Recent Developments/Updates
 Table 77. KitoZyme Company Information
 Table 78. KitoZyme Description and Business Overview
 Table 79. KitoZyme Medical Grade Chitosan Sales (Ton), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
 Table 80. KitoZyme Medical Grade Chitosan Product
 Table 81. KitoZyme Recent Developments/Updates
 Table 82. BIO21 Company Information
 Table 83. BIO21 Description and Business Overview
 Table 84. BIO21 Medical Grade Chitosan Sales (Ton), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
 Table 85. BIO21 Medical Grade Chitosan Product
 Table 86. BIO21 Recent Developments/Updates
 Table 87. YSK Company Information
 Table 88. YSK Description and Business Overview
 Table 89. YSK Medical Grade Chitosan Sales (Ton), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
 Table 90. YSK Medical Grade Chitosan Product
 Table 91. YSK Recent Developments/Updates
 Table 92. Vietnam Food Company Information
 Table 93. Vietnam Food Description and Business Overview
 Table 94. Vietnam Food Medical Grade Chitosan Sales (Ton), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
 Table 95. Vietnam Food Medical Grade Chitosan Product
 Table 96. Vietnam Food Recent Developments/Updates
 Table 97. NovaMatrix Company Information
 Table 98. NovaMatrix Description and Business Overview
 Table 99. NovaMatrix Medical Grade Chitosan Sales (Ton), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
 Table 100. NovaMatrix Medical Grade Chitosan Product
 Table 101. NovaMatrix Recent Developments/Updates
 Table 102. KIMICA Company Information
 Table 103. KIMICA Description and Business Overview
 Table 104. KIMICA Medical Grade Chitosan Sales (Ton), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
 Table 105. KIMICA Medical Grade Chitosan Product
 Table 106. KIMICA Recent Developments/Updates
 Table 107. Heppe Medical Chitosan GmbH Company Information
 Table 108. Heppe Medical Chitosan GmbH Description and Business Overview
 Table 109. Heppe Medical Chitosan GmbH Medical Grade Chitosan Sales (Ton), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
 Table 110. Heppe Medical Chitosan GmbH Medical Grade Chitosan Product
 Table 111. Heppe Medical Chitosan GmbH Recent Developments/Updates
 Table 112. ChitoLytic Company Information
 Table 113. ChitoLytic Description and Business Overview
 Table 114. ChitoLytic Medical Grade Chitosan Sales (Ton), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
 Table 115. ChitoLytic Medical Grade Chitosan Product
 Table 116. ChitoLytic Recent Developments/Updates
 Table 117. Golden-Shell Pharmaceutical Company Information
 Table 118. Golden-Shell Pharmaceutical Description and Business Overview
 Table 119. Golden-Shell Pharmaceutical Medical Grade Chitosan Sales (Ton), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
 Table 120. Golden-Shell Pharmaceutical Medical Grade Chitosan Product
 Table 121. Golden-Shell Pharmaceutical Recent Developments/Updates
 Table 122. Zhejiang Fengrun Biotech Company Information
 Table 123. Zhejiang Fengrun Biotech Description and Business Overview
 Table 124. Zhejiang Fengrun Biotech Medical Grade Chitosan Sales (Ton), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
 Table 125. Zhejiang Fengrun Biotech Medical Grade Chitosan Product
 Table 126. Zhejiang Fengrun Biotech Recent Developments/Updates
 Table 127. Jiangsu Shuanglin Company Information
 Table 128. Jiangsu Shuanglin Description and Business Overview
 Table 129. Jiangsu Shuanglin Medical Grade Chitosan Sales (Ton), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
 Table 130. Jiangsu Shuanglin Medical Grade Chitosan Product
 Table 131. Jiangsu Shuanglin Recent Developments/Updates
 Table 132. Jiangsu Aoxin Biotechnology Company Information
 Table 133. Jiangsu Aoxin Biotechnology Description and Business Overview
 Table 134. Jiangsu Aoxin Biotechnology Medical Grade Chitosan Sales (Ton), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
 Table 135. Jiangsu Aoxin Biotechnology Medical Grade Chitosan Product
 Table 136. Jiangsu Aoxin Biotechnology Recent Developments/Updates
 Table 137. Qingdao Yunzhou Biochemistry Company Information
 Table 138. Qingdao Yunzhou Biochemistry Description and Business Overview
 Table 139. Qingdao Yunzhou Biochemistry Medical Grade Chitosan Sales (Ton), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
 Table 140. Qingdao Yunzhou Biochemistry Medical Grade Chitosan Product
 Table 141. Qingdao Yunzhou Biochemistry Recent Developments/Updates
 Table 142. Key Raw Materials Lists
 Table 143. Raw Materials Key Suppliers Lists
 Table 144. Medical Grade Chitosan Distributors List
 Table 145. Medical Grade Chitosan Customers List
 Table 146. Medical Grade Chitosan Market Trends
 Table 147. Medical Grade Chitosan Market Drivers
 Table 148. Medical Grade Chitosan Market Challenges
 Table 149. Medical Grade Chitosan Market Restraints
 Table 150. Research Programs/Design for This Report
 Table 151. Key Data Information from Secondary Sources
 Table 152. Key Data Information from Primary Sources
 Table 153. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Medical Grade Chitosan
 Figure 2. Global Medical Grade Chitosan Market Value by Source (US$ Million), 2021–2032
 Figure 3. Global Medical Grade Chitosan Market Share by Source: 2025 & 2032
 Figure 4. Marine (Crustacean-derived) Product Picture
 Figure 5. Fungal (Non-animal) Product Picture
 Figure 6. Global Medical Grade Chitosan Market Value by Form (US$ Million), 2021–2032
 Figure 7. Global Medical Grade Chitosan Market Share by Form: 2025 vs 2032
 Figure 8. Powder/Flake Product Picture
 Figure 9. Salts & Derivatives Product Picture
 Figure 10. Global Medical Grade Chitosan Market Value by Channel (US$ Million), 2021–2032
 Figure 11. Global Medical Grade Chitosan Market Share by Channel: 2025 vs 2032
 Figure 12. Direct Sale Product Picture
 Figure 13. Indirect Sale Product Picture
 Figure 14. Global Medical Grade Chitosan Market Value by Application (US$ Million), 2021–2032
 Figure 15. Global Medical Grade Chitosan Market Share by Application: 2025 & 2032
 Figure 16. Wound Care & Exudate Management
 Figure 17. Hemostats & Emergency Care
 Figure 18. Pharma Excipients & Drug Delivery
 Figure 19. Tissue Engineering & Regenerative Medicine
 Figure 20. Medical Cosmetology
 Figure 21. Other Medical Uses
 Figure 22. Global Medical Grade Chitosan Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 23. Global Medical Grade Chitosan Market Size (US$ Million), 2021–2032
 Figure 24. Global Medical Grade Chitosan Sales (Ton), 2021–2032
 Figure 25. Global Medical Grade Chitosan Average Price (US$/Kg), 2021–2032
 Figure 26. Medical Grade Chitosan Report Years Considered
 Figure 27. Medical Grade Chitosan Sales Share by Manufacturers in 2025
 Figure 28. Global Medical Grade Chitosan Revenue Share by Manufacturers in 2025
 Figure 29. Top 5 and Top 10 Global Medical Grade Chitosan Players: Market Share by Revenue in Medical Grade Chitosan in 2025
 Figure 30. Medical Grade Chitosan Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 31. Global Medical Grade Chitosan Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 32. North America Medical Grade Chitosan Sales Market Share by Country (2021–2032)
 Figure 33. North America Medical Grade Chitosan Revenue Market Share by Country (2021–2032)
 Figure 34. U.S. Medical Grade Chitosan Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Canada Medical Grade Chitosan Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. Europe Medical Grade Chitosan Sales Market Share by Country (2021–2032)
 Figure 37. Europe Medical Grade Chitosan Revenue Market Share by Country (2021–2032)
 Figure 38. Germany Medical Grade Chitosan Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. France Medical Grade Chitosan Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. U.K. Medical Grade Chitosan Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Italy Medical Grade Chitosan Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Russia Medical Grade Chitosan Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Asia Pacific Medical Grade Chitosan Sales Market Share by Region (2021–2032)
 Figure 44. Asia Pacific Medical Grade Chitosan Revenue Market Share by Region (2021–2032)
 Figure 45. China Medical Grade Chitosan Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Japan Medical Grade Chitosan Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. South Korea Medical Grade Chitosan Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. India Medical Grade Chitosan Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Australia Medical Grade Chitosan Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Taiwan Medical Grade Chitosan Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Indonesia Medical Grade Chitosan Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Thailand Medical Grade Chitosan Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. Malaysia Medical Grade Chitosan Revenue Growth Rate (US$ Million), 2021–2032
 Figure 54. Philippines Medical Grade Chitosan Revenue Growth Rate (US$ Million), 2021–2032
 Figure 55. Latin America Medical Grade Chitosan Sales Market Share by Country (2021–2032)
 Figure 56. Latin America Medical Grade Chitosan Revenue Market Share by Country (2021–2032)
 Figure 57. Mexico Medical Grade Chitosan Revenue Growth Rate (US$ Million), 2021–2032
 Figure 58. Brazil Medical Grade Chitosan Revenue Growth Rate (US$ Million), 2021–2032
 Figure 59. Argentina Medical Grade Chitosan Revenue Growth Rate (US$ Million), 2021–2032
 Figure 60. Middle East and Africa Medical Grade Chitosan Sales Market Share by Country (2021–2032)
 Figure 61. Middle East and Africa Medical Grade Chitosan Revenue Market Share by Country (2021–2032)
 Figure 62. Turkey Medical Grade Chitosan Revenue Growth Rate (US$ Million), 2021–2032
 Figure 63. Saudi Arabia Medical Grade Chitosan Revenue Growth Rate (US$ Million), 2021–2032
 Figure 64. UAE Medical Grade Chitosan Revenue Growth Rate (US$ Million), 2021–2032
 Figure 65. Global Sales Market Share of Medical Grade Chitosan by Source (2021–2032)
 Figure 66. Global Revenue Market Share of Medical Grade Chitosan by Source (2021–2032)
 Figure 67. Global Medical Grade Chitosan Price (US$/Kg) by Source (2021–2032)
 Figure 68. Global Sales Market Share of Medical Grade Chitosan by Application (2021–2032)
 Figure 69. Global Revenue Market Share of Medical Grade Chitosan by Application (2021–2032)
 Figure 70. Global Medical Grade Chitosan Price (US$/Kg) by Application (2021–2032)
 Figure 71. Medical Grade Chitosan Value Chain
 Figure 72. Channels of Distribution (Direct Vs Distribution)
 Figure 73. Bottom-up and Top-down Approaches for This Report
 Figure 74. Data Triangulation
 Figure 75. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

Global Chitosan for Medical Market Research Report 2025
Global Vegetal and Fungal Chitosan Market Research Report 2025
Global Chitosanase Market Insights Forecast to 2030
Global Medical Chitin Market Research Report 2025
Medical Chitosan Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Chitosan for Agriculture Market Research Report 2025
Global Chitosan for Food and Beverages Market Research Report 2025
Chitosan based Biomaterial Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Food Grade Chitosan Market Research Report 2025
Global Medical Chitosan Fibers Market Research Report 2025
Global Chitosan Powders Market Research Report 2024
Global Chitosan for Cosmetics Market Research Report 2025
Global Chitosan Derivatives Market Insights Forecast to 2030
Medical grade Chitin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Industrial Grade Chitin Market Research Report 2024
Global Chitosan for Water and Waste Treatment Market Research Report 2025
Global Linear Chitosan Market Research Report 2024
Global Chitosan Oligosaccharide Market Research Report 2024
Chitosan Nanoparticles Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Chitosan HCl Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions